KATHRYN BARTON: Open Payments
NPI 1275868713 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$984 in 49 payments from 17 companies in 2025. Trend: 2023 $1,211 · 2024 $1,118 · 2025 $984
Food & beverage: $984
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $278 |
| AstraZeneca Pharmaceuticals LP | 13 | $237 |
| ABBVIE INC. | 5 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| Exact Sciences Corporation | 2 | $37 |
| Lilly USA, LLC | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
Products named: Ozempic, AIRSUPRA, FARXIGA, CAPLYTA, Auvelity, JARDIANCE, REXULTI, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
